WO2015102019A3 - Procédé de préparation de polymorphes de chlorhydrate de 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide - Google Patents
Procédé de préparation de polymorphes de chlorhydrate de 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide Download PDFInfo
- Publication number
- WO2015102019A3 WO2015102019A3 PCT/IN2014/000801 IN2014000801W WO2015102019A3 WO 2015102019 A3 WO2015102019 A3 WO 2015102019A3 IN 2014000801 W IN2014000801 W IN 2014000801W WO 2015102019 A3 WO2015102019 A3 WO 2015102019A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- indol
- piperazinyl
- cyano
- butyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention concerne un sel d'acide formique ainsi que sa forme cristalline d'un médicament antidépresseur à savoir, un composé de 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide de formule 1a, qui est utile dans la préparation du composé de chlorhydrate de 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide de formule 1b et son procédé de préparation.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN6150/CHE/2013 | 2013-12-30 | ||
| IN732/CHE/2014 | 2014-02-17 | ||
| IN6150CH2013 IN2013CH06150A (fr) | 2013-12-30 | 2014-12-29 | |
| IN732CH2014 IN2014CH00732A (fr) | 2014-02-17 | 2014-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2015102019A2 WO2015102019A2 (fr) | 2015-07-09 |
| WO2015102019A3 true WO2015102019A3 (fr) | 2015-08-27 |
Family
ID=53494170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2014/000801 Ceased WO2015102019A2 (fr) | 2013-12-30 | 2014-12-29 | Procédé de préparation de polymorphes de chlorhydrate de 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2015102019A2 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002102794A2 (fr) * | 2001-06-19 | 2002-12-27 | Merck Patent Gmbh | Formes polymorphes de chlorhydrate de 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine |
| US7829723B2 (en) * | 2005-05-26 | 2010-11-09 | Vertex Pharmaceuticals Incorporated | Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate |
| CN102977083A (zh) * | 2012-12-17 | 2013-03-20 | 南京海纳医药科技有限公司 | 1-[4-(5-氰基吲哚-3-基)丁基]-4-(2-氨甲酰-苯并呋喃-5-基)-哌嗪盐酸盐的新晶型xⅶ及其制备方法 |
-
2014
- 2014-12-29 WO PCT/IN2014/000801 patent/WO2015102019A2/fr not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002102794A2 (fr) * | 2001-06-19 | 2002-12-27 | Merck Patent Gmbh | Formes polymorphes de chlorhydrate de 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine |
| US7829723B2 (en) * | 2005-05-26 | 2010-11-09 | Vertex Pharmaceuticals Incorporated | Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate |
| CN102977083A (zh) * | 2012-12-17 | 2013-03-20 | 南京海纳医药科技有限公司 | 1-[4-(5-氰基吲哚-3-基)丁基]-4-(2-氨甲酰-苯并呋喃-5-基)-哌嗪盐酸盐的新晶型xⅶ及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015102019A2 (fr) | 2015-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014KN00948A (fr) | ||
| WO2012044727A3 (fr) | Procédé de fabrication de dérivés de pyrimidine | |
| WO2014195978A3 (fr) | Procédé pour la préparation de (3r,4r)-4-méthyl-3-(méthyl-7h-pyrrolo[2,3-d]pyrimidine-4-yl-amino)-ss-oxo-1-pipéridine-propanenitrile et de ses sels | |
| HK1200812A1 (en) | Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine | |
| PH12013500301A1 (en) | Oxadiazole inhibitors of leukotriene production | |
| EA201691538A1 (ru) | Способ получения солей вортиоксетина | |
| HK1220193A1 (zh) | 酪氨酸激酶抑制剂及其盐的晶体形式 | |
| WO2015068175A3 (fr) | Procédé perfectionné de préparation de pazopanib ou d'un sel de qualité pharmaceutique de celui-ci | |
| ZA201604932B (en) | N1-(3,3,3-trifluoro-2-hydroxo-2-methylpropionyl)-piperidine derivatives as inhibitors of pyruvate dehydrogenase kinase | |
| WO2016135747A3 (fr) | Processus de préparation d'un composé amorphe (1s)-1,5-anhvdro-1-[3- [[5- (4 fluorophényl)-2-thiényl]methvl]-4-méthylphényl]-d-glucitol et de ses formes polymorphes | |
| WO2014049612A3 (fr) | Procédés et polymorphes de 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-pipérazinyl]-2-benzofuran carboxamide et ses sels | |
| CA2922375C (fr) | Formes de sels d'alpha-tea: compositions et utilisations therapeutiques | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| EA201792422A1 (ru) | Способ получения 2-{4-[2-({[2-(4-хлорфенил)-1,3-тиазол-4-ил]метил}сульфанил)-3,5-дициан-6-(пирролидин-1-ил)пиридин-4-ил]фенокси}этил-l-аланил-l-аланинат моногидрохлорида | |
| WO2016142819A3 (fr) | Nouveau procédé de préparation de ranolazine | |
| HK1212978A1 (zh) | 芥子酸的新型衍生物 | |
| WO2015128882A3 (fr) | Formes cristallines de n-(2,4-di-tert-butyl -5-hydroxyphényl)-1,4-dihydro -4-oxoquinoléine-3-carboxamide et procédé de préparation de celles-ci | |
| NZ720805A (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| EA201790522A1 (ru) | Соль производного цефалоспорина, ее кристаллическое твердое вещество и способ ее получения | |
| WO2015102019A3 (fr) | Procédé de préparation de polymorphes de chlorhydrate de 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-pipérazinyl]-2-benzofuranne carboxamide | |
| IN2014CH00732A (fr) | ||
| WO2017029642A3 (fr) | Nouveaux polymorphes du dolutégravir et leurs sels | |
| WO2014125233A3 (fr) | Procédé de synthèse de 4-piperidin-4-yl-benzène-1,3-diol et de ses sels et nouveau composé 4-(2,4-dihydroxy-phényl)-4-hydroxy-piperidine-1-carboxylate de tert-butyle | |
| WO2014167509A3 (fr) | Polymorphes de loxoprofène et leur procédé de préparation | |
| WO2014024203A8 (fr) | Procédé perfectionné pour la préparation de chlorhydrate de dexméthylphénidate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14877207 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14877207 Country of ref document: EP Kind code of ref document: A2 |